Podcasts about outcomes

Join Jeff, Jim, and special guest Ian Glazer at the Gartner IAM Summit 2025 as they discuss the Identity and Access Management (IAM) industry, the evolution of IAM practices, and the exciting new concepts like Continuous Identity. They delve into topics such as the impact of AI, shared signals framework, and the struggles and triumphs of identity practitioners. Plus, hear about the Digital Identity Advancement Foundation's mission and enjoy some lighter moments with tales of 'chuckles' and supper clubs. Don't miss this insightful and entertaining episode of the Identity at the Center podcast.Connect with Ian: https://www.linkedin.com/in/iglazer/Connect with us on LinkedIn:Jim McDonald: https://www.linkedin.com/in/jimmcdonaldpmp/Jeff Steadman: https://www.linkedin.com/in/jeffsteadman/Visit the show on the web at http://idacpodcast.comTimestamps00:00 Introduction and Casual Banter00:50 Conference Highlights and Podcast Milestones03:00 Introducing Ian Glazer05:43 Digital Identity Advancement Foundation (DIF)08:09 Challenges in Identity Governance and Administration (IGA)13:28 Continuous Identity: A Paradigm Shift22:31 Real-World Applications and Organizational Impact31:51 Realistic Security Measures32:28 Maturity of Identity and Access Management34:54 Skills and Challenges in IAM36:44 Metrics and Outcomes in IAM40:23 Identity Practitioner Skills41:19 Solving Problems with AI46:21 Continuous Identity and Future Trends48:45 Identity Salon and Community54:19 Wrapping Up and Future EventsKeywordsIan Glazer, Continuous Identity, Shared Signals Framework, CAEP, Gartner IAM Summit, Identity Security, Joiner Mover Leaver, IGA, Access Certification, Identity Salon, IDAC, Identity at the Center, Jeff Steadman, Jim McDonald, IAM, Cybersecurity, Non-Human Identity, Identity Practitioner, DIAF

Rest and let God determine your outcomes.

Managed Service Providers (MSPs) are encouraged to shift their focus from traditional infrastructure management to becoming Managed Intelligence Providers (MIPs), emphasizing the integration of artificial intelligence (AI) into their service offerings. Chance Weaver, VP of AI Adoption at PAX 8, highlights the necessity for MSPs to engage in deeper conversations with clients about their business processes rather than merely discussing technology tools. This approach aims to identify specific business challenges that can be addressed through tailored technological solutions, including AI, automation, and business intelligence.Weaver notes that while many MSPs have historically excelled in maintaining infrastructure, they often lack a comprehensive understanding of their clients' workflows and business needs. The transition to MIPs involves not only understanding business processes but also ensuring data readiness, which is critical for effective AI implementation. Instead of undertaking extensive data cleanup projects upfront, MSPs should focus on the data relevant to specific business processes, thereby demonstrating immediate ROI and building trust with clients.The episode also discusses the importance of outcome-driven services and the potential for MSPs to monetize AI solutions effectively. Weaver shares insights from his interviews with over 650 partners in the PAX 8 ecosystem, revealing that only a small percentage are currently generating revenue from AI-related services. Successful partners are leveraging their existing relationships and expertise to create value for clients by aligning pricing models with measurable outcomes, thus facilitating a smoother transition to AI adoption.For MSPs and IT service leaders, the key takeaway is the urgency to start conversations about AI with clients, even if they are not yet fully equipped to implement these solutions. By positioning themselves as knowledgeable partners in the AI transformation journey, MSPs can capitalize on emerging opportunities and enhance their service offerings. The discussion emphasizes that while some providers may choose to adopt a fast-follower strategy, those who proactively engage with clients about AI will likely gain a competitive advantage in the evolving market landscape.

Pool Pros text questions hereIn the conclusion of Natalie Hood's conversation with Ryan Walker, the focus shifts from “selling pool stuff” to selling outcomes: experience, lifestyle, confidence, and trust. This episode pulls the curtain back on what's really happening in today's retail and builder sales environment—homeowners aren't shopping locally anymore. They're shopping globally through TikTok, Instagram, and Pinterest, then walking into your store or your design meeting with Dubai-level expectations and a Michigan budget… and they still want you to make it real.Ryan breaks down why dealers and retailers can't win by being defensive, dismissive, or stuck in “this is how we've always done it.” Instead, the winning move is customer-centric discovery: show what's possible, guide the customer through tradeoffs, and give them a solution—not a shutdown. Along the way, the conversation hits pricing psychology, upselling ethically, supplier partnerships, training your staff in the off-season, and why one bad review can punch harder than ten great ones.What This Episode CoversSelling the vision, not just the pool Homeowners aren't buying “a body of water.” They're buying backyard life that replaces travel, replaces entertainment, and becomes the family experience hub. Pools (and even above-ground setups) have evolved into full environments—decks, lighting, wellness add-ons, the whole vibe.Why “cheap” isn't the conversation anymore With pool projects regularly crossing the $100K mark, obsessing over saving $50–$200 can be meaningless against the total investment (and the loan). The real job is to help the buyer spend smarter, not just spend less.Social media has changed the customer's brain Customers aren't looking at “what sells in this zip code.” They're looking at what looks insane on a reel. Dealers who don't adapt to global inspiration trends risk sounding outdated or dismissive—and that's how you lose the room (and the sale).Dealers must stop taking trends personally If a customer brings you an idea that's unrealistic or “not right for your market,” the answer isn't a slammed door. The answer is:explain why it's hard,explain what it would require,and offer an alternative solution that gets the same feeling with fewer headaches.How to upsell without being gross Ryan points out that strong sales isn't pressure—it's clarity. Customers want you to guide them. If you can retain attention, build trust, and connect features to outcomes, you can justify premium choices without acting like a carnival barker.Heat pump myth-busting (yes, even in cold markets) The episode calls out the “heat pumps don't work here” mindset and reframes it: heat pumps work in Canada, and Canada is colder than Michigan. Translation: the barrier isn't physics—it's explanation and expectation-setting.Supplier relationships: stop waiting to be visited Reps cover huge territories and get flooded with requests. If you want training, product support, or attention—ask for it. Call. Get the rep's number from the distributor. The hungriest dealers get the most support because they create the reason to show up.Off-season is training season Retail's biggest killer: bad reviews Training staff f Support the showThank you so much for listening! You can find us on social media: Facebook Instagram Tik Tok Email us: talkingpools@gmail.com

Every January, men make promises to themselves. They commit to getting healthier. More disciplined. More focused. More present. And within weeks, most of those promises are broken. Not because men don't care. Not because they're lazy. Not because they lack discipline. But because most men were never taught how real change actually works. In this episode of REBUILT, Michael-David breaks down why New Year's resolutions fail and what it truly takes to follow through, not through motivation or willpower, but through identity-level change. You'll learn: > Why most men quit early (and why it's not your fault) > How your brain resists change to protect you, not sabotage you > The 6 pillars of real transformation: Focus, Thoughts, Beliefs, Decisions, Actions, Outcomes > Why tying habits to identity works better than chasing outcomes > How starting too big guarantees failure and how small steps build unstoppable momentum > The neuroscience behind habits, consistency, and confidence > Why action silences anxiety and overthinking > How faith, alignment, and discipline work together to shape the man God is calling you to become Michael-David also shares a real coaching story that shows how one man stopped the start–stop cycle and built lasting health by shrinking the first step and reinforcing identity instead of perfection. This episode isn't about hype. It's about clarity. Alignment. And becoming the man you keep telling yourself you want to be. If you're tired of starting over every January, this conversation will change how you approach the year ahead.

Want to 10x your team's output? The secret isn't working harder, it's aligning incentives.In this episode, Mike breaks down the most powerful leadership tool you're probably not using: AI (Aligned Incentives). Learn how to structure compensation plans that get your team thinking about your business even in the shower, and why paying someone more money might be the smartest financial decision you'll ever make.Mike covers:Why hourly pay actually incentivizes slower workThe difference between leading and lagging indicatorsHow to structure comp plans for sales reps, painters, and crew leadsThe "shower time" test: are your team members thinking about your business off the clock?Why you should never be attached to a salary cap for any roleWhether you're managing painters, production managers, or an entire leadership team, this episode will change how you think about compensation forever. Stop paying for time and start paying for outcomes.

If your goals rarely stick past January, this episode breaks down why traditional goal setting fails — and how to set goals that match your capacity, identity, and real life so 2026 actually feels different. In this episode, we challenge the way most people approach goal setting and explain why motivation-based or overly rigid goals often lead to burnout instead of progress. We walk through a more sustainable framework that focuses on identity, consistency, and realistic capacity rather than perfection. You'll learn how to shift from "what do I want to achieve?" to "who do I need to become?" — and how that mindset creates long-term change across health, habits, business, and life. If you're ready to plan for 2026 without pressure or self-judgment, this conversation will ground you.   What You'll Learn: Why SMART goals aren't enough on their own The difference between outcome-based vs. identity-based goals How to set goals based on your current capacity, not ideal motivation How to break goals into quarterly, monthly, and weekly behaviors Setting 2026 goals without putting your life on hold   Chapters: 00:50 - Welcome to The Wellness Effect + New Year Intentions 01:27 - Why 80–90% of New Year's Goals Don't Stick 11:35 - The Missing Link in Goal Setting (Identity vs Outcomes) 15:05 - Who Do You Need to Become to Reach Your Goals? 18:45 - Capacity-Based Goals: Floor vs Ceiling 22:18 - Behavior-Based Goals That Actually Create Change 27:40 - Consistency Over Motivation (What Really Works) 39:50 - Applying Identity-Based Goals to Health & Life 55:40 - When Goals Shift as Your Life Changes 57:45 - Why We've Stopped Setting Arbitrary Numbers   Resources: Use code "Wellness Effect" for FREE Functional Lab Test when you enter our Root Cause Reset Program.    Want to Work With Us? If this episode feels like the missing piece in your healing journey, connect with us below: Visit our website: https://www.lifestyleucoaching.ca/ Follow us on Instagram: The Podcast: https://www.instagram.com/wellnesseffectpod/ Lacey Iskra - https://www.instagram.com/laceeiskk/ Jensen - https://www.instagram.com/wellnesswjensen/ Kira Iskra - https://www.instagram.com/kiraiskk/ Lifestyle U have helped over 1,000+ women transform their mind and body and become the best version of themselves. Want to be next? Click Here to Apply! - https://www.lifestyleucoaching.ca/apply If you loved this episode and want to hear more, subscribe and leave a review! Share this episode with a friend who's ready to start their own wellness journey. Follow us on Instagram at @wellnesseffectpod to stay up-to-date with the latest episodes and tips.  

Brian Skrobonja closes out the year with a milestone episode that marks the final episode of 2025 and the conclusion of this version of the show. He shares the gratitude he feels for the listeners who have supported the mission, the team whose work brought each idea to life, and the recognition the podcast received from Forbes as one of the top shows by financial advisors. Tune in to hear Brian reflect on why he started this podcast, how the mission has been accomplished, and why this moment isn't an ending but the beginning of a bigger vision that will unfold in 2026. He also shares the three core truths that can reshape your financial future if you're ready to take them to heart and take action. Brian reveals that today's episode is a meaningful milestone. It closes out the year and marks the end of this version of the show. He takes a moment to thank the listeners, the production team, and Forbes for recognizing the podcast among the top in the industry. He reflects on why he started the podcast in the first place: To cut through the constant misinformation about money and share the strategies his team uses to help people achieve real financial results. Looking back, he believes that mission has been accomplished.  Brian makes it clear that this is not an ending but a transition into something bigger. He shares that a complete rebrand and new platform will be announced in 2026, designed to serve listeners at a much higher level. Before signing off, he leaves the audience with three core truths that can transform their financial future. Truth #1: Not all financial advisors are the same. Some sell products, while others build full plans that protect your assets and future. Learn how to spot the difference so your plan always comes first. Truth #2: Chasing interest rates won't make you wealthy. True financial success is about outcomes, not chasing quick wins. When your plan dictates the strategy, your money finally works for your life. Truth #3: Stop procrastinating. According to Brian, waiting for the perfect moment or strategy only delays your security and peace of mind. Taking action now, even imperfectly, moves you toward real results and freedom. Brian explains how a real financial plan protects more than your investments. It covers taxes, estate planning, long-term care, Social Security timing, and income planning. With a holistic plan, you stop guessing and start living with security and clarity. Learn why a plan comes before products. Products like stocks or insurance aren't your strategy, they are tools your plan uses to achieve your goals. When you focus on planning first, every financial move has purpose and impact. Brian reveals how to choose the right financial advisor. Look for someone who brings tax, legal, and comprehensive planning expertise to the table. The right advisor helps you use your money to build the life you want. For Brian, the secret to building wealth is taking imperfect action. Waiting for the perfect strategy or market conditions rarely works. Brian shows how moving forward, even with small steps, creates momentum and confidence.  Brian explains why financial clarity beats short-term gains. Rates of return and interest are important, but they don't define success. Outcomes, security, and a plan that fits your life always win in the long term. Even as this podcast chapter closes, bigger opportunities and tools are coming to serve you at a higher level.     Mentioned in this episode: BrianSkrobonja.com SkrobonjaFinancial.com SkrobonjaWealth.com BUILDbanking.com Common Sense Financial Podcast on YouTube  Common Sense Financial Podcast on Spotify     Alternative investments may be subject to less regulation than other types of pooled investment vehicles. Alternative Investments may impose significant fees, including incentive fees that are based upon a percentage of the realized and unrealized gains and an individual's net returns may differ significantly from actual returns. Such fees may offset all or a significant portion of such Alternative Investment's trading profits. Incorporating alternative investments into a portfolio presents the opportunity for significant losses including in some cases, losses which exceed the principal amount invested. Also, some alternative investments have experienced periods of extreme volatility and in general, are not suitable for all investors. Asset allocation and diversification strategies do not ensure profit or protect against loss in declining markets ---- BUILD Banking™ is a DBA of Skrobonja Insurance Services, LLC. Benefits and guarantees are based on the claims paying ability of the insurance company. Not FDIC insured. Results may vary. Any descriptions involving life insurance policies and its use as an alternative form of financing or risk management techniques are provided for illustration purposes only, will not apply in all situations, may not be fully indicative of any present or future investments, and may be changed at the discretion of the insurance carrier, General Partner and/or Manager and are not intended to reflect guarantees on securities performance. The term BUILD Banking™, private banking alternatives or specially designed life insurance contracts (SDLIC) are not meant to insinuate that the issuer is creating a real bank for its clients or communicating that life insurance companies are the same as traditional banking institutions. This material is educational in nature and should not be deemed as a solicitation of any specific product or service. BUILD Banking™ is offered by Skrobonja Insurance Services, LLC only and is not offered by Madison Avenue Securities, LLC. nor Skrobonja Wealth Management, LLC. ---- This content is intended for informational purposes only. It is not intended to be used as the sole basis for financial decisions, nor should it be construed as advice designed to meet the particular needs of an individual's situation. Skrobonja Financial Group, LLC, Skrobonja Insurance Services, LLC, Skrobonja Wealth Management, LLC are not permitted to offer and no statement made during this presentation shall constitute tax or legal advice. Our firms are not affiliated with or endorsed by the U.S. Government or any governmental agency. The information and opinions contained herein provided by third parties have been obtained from sources believed to be reliable, but accuracy and completeness cannot be guaranteed by Skrobonja Financial Group, LLC, Skrobonja Insurance Services, LLC, Skrobonja Wealth Management, LLC. ---- Securities offered only by duly registered individuals through Madison Avenue Securities, LLC. (MAS), Member FINRA &SIPC. Advisory services offered only by duly registered individuals through Skrobonja Wealth Management (SWM), a registered investment advisor. Tax services offered only through Skrobonja Tax Consulting. MAS does not offer Build Banking or tax advice. Skrobonja Financial Group, LLC, Skrobonja Wealth Management, LLC, Skrobonja Insurance Services, LLC, Skrobonja Tax Consulting, and Build Banking are not affiliated with MAS. Skrobonja Wealth Management, LLC is a registered investment adviser. Advisory services are only offered to clients or prospective clients where Skrobonja Wealth Management, LLC and its representatives are properly licensed or exempt from licensure. The firm is a registered investment adviser with the state of Missouri, and may only transact business with residents of those states, or residents of other states where otherwise legally permitted subject to exemption or exclusion from registration requirements. Registration with the United States Securities and Exchange Commission or any state securities authority does not imply a certain level of skill or training. Skrobonja Wealth Management has no ownership interest, compensation arrangement, revenue-sharing agreement, or other economic relationship with Veta Investment Partners. We may allocate a portion of a client's portfolio to strategies managed by Veta Investment Partners when we determine that the allocation is appropriate for the client's objectives, risk tolerance, and overall portfolio design. Our selection of Veta's strategies is based solely on the merits of the investment and the needs of the client, and not on any financial relationship between our firms.

Greg Brady talked to Peter Moreira, Chief of Police for Durham Regional Police Service, to discuss not just the 64 arrests and 155 charges from a recent retail theft crackdown, but also how Durham Regional Police monitors repeat offenders, supports local businesses, and works with Crown prosecutors and community partners to drive lasting change. Learn more about your ad choices. Visit megaphone.fm/adchoices

Greg Brady talked to Peter Moreira, Chief of Police for Durham Regional Police Service, to discuss not just the 64 arrests and 155 charges from a recent retail theft crackdown, but also how Durham Regional Police monitors repeat offenders, supports local businesses, and works with Crown prosecutors and community partners to drive lasting change. Learn more about your ad choices. Visit megaphone.fm/adchoices

Researchers evaluated the efficacy and outcomes of complete surgical excision of perianal melanomas from 59 horses. Read the full article here: https://equimanagement.com/research-medical/research/treatment-outcomes-for-perianal-melanoma-removal-in-horses/Mentioned in this episode:EquiManagement on Audio All the articles you have come to love in EquiManagement Magazine are now available in this podcast for free. Each article is released as its own separate episode to make them quick and easy to listen to. EquiManagement always has the latest insights on equine health, veterinary practice management, and veterinarian wellness.

What if the universe has been leaving you breadcrumbs all along, and you've been too busy planning to notice them?Host, Dr. Katie Deming shares how she completely transformed her approach to life after her shared death experience and leaving Western medicine. Instead of forcing goals and pushing through obstacles, she now follows signs and synchronicities that appear in her daily life. She explains the difference between these two concepts and why paying attention to them opens up possibilities you could never plan for yourself. Through personal stories that range from broken laptops to missing keys, she shows how even frustrating moments might be protecting you from something you can't see yet.The heart of the conversation centers on a remarkable story involving a Rolex watch, a midnight intuition, and a dating app Dr. Katie swore she'd never use. What unfolded demonstrates how following seemingly illogical guidance can lead to connections and openings that feel almost magical. Chapters:00:04:10 - Stop Forcing the Plan00:07:02 - Closing a Cycle, Opening a New One00:14:30 - Her Midnight Nudge00:24:30 - When Life Delays You for a Reason00:32:44 - Surrender to What Is, Then Follow the SignsDr. Katie also gets vulnerable about recent losses in her business and personal life, revealing how she's learned to recognize when it's time to let go rather than get dragged through the gravel trying to hold on.Dr. Katie explains how this approach applies directly to healing, particularly when you're faced with a diagnosis that feels like it's derailing your plans.Listen and Learn how to understand why following signs requires patience, how to avoid getting attached to outcomes, and what happens when you trust that the magic ahead is better than anything you could orchestrate yourself.Access the FREE Water Fasting Masterclass Now: https://www.katiedeming.com/the-healing-power-of-fasting/ Transform your hydration with the system that delivers filtered, mineralized, and structured water all in one. Spring Aqua System: https://springaqua.info/drkatieDownload the FREE Healing Tools Guide: https://bit.ly/drkatie-giftguide MORE FROM KATIE DEMING M.D. Work with Dr. Katie: www.katiedeming.com 6 Pillars of Healing Cancer Workshop Series - Click Here to Enroll Follow Dr. Katie Deming on Instagram: https://www.instagram.com/katiedemingmd/ Email: INFO@KATIEDEMING.COM Please Support the Show Share this episode with friends & family Give a Review on Spotify Give a Review on Apple Podcast Watch on Youtube: https://youtube.com/playlist?list=PL5LplU70TE9i01tW_7Tozi8b6X6rGBKA2&si=ZXLy5PjM7daD6AV5 DISCLAIMER: The Born to Heal Podcast is intended for informational purposes only and is not a substitute for seeking professional medical advice, diagnosis, or treatment. Individual medical histories are unique; therefore, this episode should not ...

As we close out an extraordinary year of Fostering Change, Rob Scheer welcomes Becky Santoro, Co-Founder and Executive Director of Foster Village Charlotte — a nonprofit reshaping foster care by focusing on the people raising and supporting children every day: foster, kinship, and birth families.A former educator and foster parent herself, Becky witnessed firsthand how overwhelmed and isolated caregivers can feel. She also saw something powerful: children thrive when the adults caring for them are supported, equipped, and connected. That realization led her to co-found Foster Village Charlotte in 2018 — a community-driven model that has since expanded nationwide through a growing network of Foster Village affiliates.Today, Becky and her team not only serve families across the Charlotte region, but also coach and mentor emerging affiliates across the U.S., helping communities build their own “village” of wraparound care. From practical resources to emotional connection to dignified, trauma-informed visitation spaces, Foster Village is reimagining what it means to care for children by caring for the caregivers who love them.

Allianz Life Insurance Company of North America's latest white paper takes a deep look at how different retirement income strategies—and especially various types of annuity products—can shape participant outcomes in a world of longer lifespans and ongoing market uncertainty.In this episode of the 401(k) Specialist Pod(k)ast, Editor-in-Chief Brian Anderson sits down with Danielle Kelso, Senior Institutional Solutions Consultant at Allianz Life, to break down the report's most compelling findings, the annuity options analyzed, and what the research reveals about improving retirement income security for today's workers.• Check out the “Measuring Retirement Income Outcomes” white paper at this link.See Also:Defining Value Creation in the Decumulation Phase with Allianz Life's Danielle KelsoExploring Guaranteed Income in DC Plan Trends with Allianz Life's Matt StubblefieldThis podcast is designed to accompany the white paper, "Measuring Retirement Income Outcomes" (LIA-381), which provides all underlying assumptions used.

As cannabis becomes more widely available and socially accepted, so does the misconception that it's safe to use during pregnancy and lactation. This course reviews updated guidance from the American College of Obstetricians and Gynecologists (ACOG), highlighting the evidence behind the risks and outlining how pharmacists can address misinformation and counsel patients effectively. You will learn how to support safe, informed decision-making that promotes the health of both parent and child.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTKevin Shea, PharmDPharmacist Vytal Options  Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify current ACOG recommendations regarding cannabis use during pregnancy and lactation.2. Describe pharmacist strategies for screening, counseling, and reducing risks associated with cannabis use during the perinatal period.Rachel Maynard and Kevin Shea have no relevant financial relationships to disclose.0.05 CEU/0.5 HrUAN: 0107-0000-25-377-H01-PInitial release date: 12/29/2025Expiration date: 12/29/2026Additional CPE details can be found here.

On this episode, our expert guests from this year's past episodes each share one critical question that customer experience (CX) leaders need to ask themselves to deliver better customer outcomes in 2026.We've compiled the most important questions from our conversations this year — each one designed to reveal where your CX strategy is vulnerable and what to do about it. Join us as we explore those questions with previous guests:Mark Abraham (co-author, Personalized: Customer Strategy in the Age of AI)Brian Breslin (vice president, fintech and SaaS, TELUS Digital)Diane Magers (co-author, The Customer Experience Field Guide)Adrian Swinscoe (author, Punk CX and Punk XL)Jelena Bajic (vice president, global operations excellence, TELUS)For more from today's guests, check out these episodes of Questions for now:On The era of AI-driven personalization is here. What now?, Mark Abraham reveals the five key promises brands must fulfill to delight customers at every interaction. On Why do satisfied customers leave?, Brian Breslin uncovers what separates customers who stay from those who leave for a better offer.On Is experience management the new customer experience?, Diane Magers explains the strategic shift to organization-wide experience management practices.On How can you alleviate cost pressures in customer experience?, Adrian Swinscoe and Jelena Bajic share strategies for delivering exceptional outcomes in CX when leaders are asked to do more with less.Visit our website to learn more about TELUS Digital.

As cannabis becomes more widely available and socially accepted, so does the misconception that it's safe to use during pregnancy and lactation. This course reviews updated guidance from the American College of Obstetricians and Gynecologists (ACOG), highlighting the evidence behind the risks and outlining how pharmacists can address misinformation and counsel patients effectively. You will learn how to support safe, informed decision-making that promotes the health of both parent and child.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTKevin Shea, PharmDPharmacist Vytal Options PRACTICE RESOURCEPurchase this course to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here. CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify current ACOG recommendations regarding cannabis use during pregnancy and lactation.2. Describe pharmacist strategies for screening, counseling, and reducing risks associated with cannabis use during the perinatal period.Rachel Maynard and Kevin Shea have no relevant financial relationships to disclose.0.05 CEU/0.5 HrUAN: 0107-0000-25-377-H01-PInitial release date: 12/29/2025Expiration date: 12/29/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

In this solo podcast, I address the broader argument against aversive tools in dog training promoted by the AVSAB and the R+-only movement.Recently, Dr. Michael Bailey, President of the American Veterinary Medical Association, commented on the use of electronic collars in dog training. That comment triggered backlash and a strong response from Dr. Lisa Radosta, President of the American College of Veterinary Behaviorists.But this presentation is not about personalities.It's about the claim that aversives never have a place in dog training.Using peer-reviewed research, learning theory, and real-world outcomes, I examine whether the “no aversives ever” position is actually supported by evidence and what happens to dogs when ideology overrides results.At the end, I invite you, the trainers and owners, to share stories of dogs who are alive today because balanced training worked when nothing else did.Outcomes matter.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

I recorded this for our Patreon. I have received a lot of positive feed back on this. So I am sharing it publicly. I hope you enjoy it. In this podcast, you'll learn the first Hermetic Principle, Mentalism, and how your mind shapes your lived reality through the meanings you assign, the attention you rehearse, and the actions you take. Chris breaks down how “raw data becomes a story, the story creates emotion, emotion pressures action, and action creates consequences,” then ties it directly to Adlerian psychology, mindset training, and practical personal responsibility. If you're into Hermetic Principles, manifestation with backbone, mental discipline, and self mastery that actually changes behavior, this episode gives you a clear framework to stop confusing interpretation with reality and start steering outcomes on purpose.You can expect concrete tools you can use immediately in relationships, work, and daily life, including widening the gap between stimulus and response, generating three plausible meanings before you react, and running an “attention audit” so you stop feeding resentment loops, doomscrolling, and negative self talk. Chris also shares a relationship repair line that turns accusation into curiosity, plus a simple morning and night practice to train your mental filter and build evidence based confidence. This is for anyone who wants stronger emotional regulation, cleaner communication, better relationships, and a spiritual lens that stays grounded in standards, values, and real world results.Disclaimer: We are not professionals. This podcast is opinioned based and from life experience. This is for entertainment purposes only. Opinions helped by our guests may not reflect our own. But we love a good conversation.Become a supporter of this podcast: https://www.spreaker.com/podcast/2-be-better--5828421/support.

Singapore reported 314 suicides in 2024, with the sharpest increase among adults aged 30 to 39. Nearly two-thirds were men. What pressures do these groups face? And what are the warning signs? Otelli Edwards and Steven Chia speak with Dr Jared Ng, a psychiatrist and the former chief of emergency and crisis care at the Institute of Mental Health, and Eugene Chong, counselling psychologist at Seeding Minds. WHERE TO SEEK HELP If you or someone you know is struggling and needs support, please consider reaching out to one of the helplines below. Youthline: +65 6436 6612 (call), 8533 9460 (text) and over email at hello [at] youthline.sg (hello[at]youthline[dot]sg). Youthline provides free mental health support to youth via phone, email or a live chat service. It runs from 9am to midnight daily. Calls outside of operating hours are redirected to Samaritans of Singapore or the Singapore Civil Defence Force for emergency medical services. Samaritans of Singapore: 1767 (call), 9151 1767 (WhatsApp text) and over email at pat [at] sos.org.sg (pat[at]sos[dot]org[dot]sg). Samaritans of Singapore provides round-the-clock confidential emotional support for individuals in crisis, thinking about or affected by suicide. The call and text-based services are operational 24 hours a day, every day of the week. National Mindline: 1771 (call), 6669 1771 (WhatsApp) and through online webchat on the http://mindline.sg/fsmh website. This is a round-the-clock confidential national-level helpline. Beyond immediate counselling, those who require more support can be directed to the appropriate care and resources. See omnystudio.com/listener for privacy information.

Today, Dave Furfaro, Luke Hedrick, and Robert Wharton discuss the PREDMETH trial published in The New England Journal of Medicine in 2025. This was a non-inferiority trial comparing prednisone to methotrexate for upfront therapy in treatment-naive sarcoidosis patients. Listen in for a break down of the trial, analysis, and clinically applicable pearls. Article and Reference Todays’ episode discusses the PREDMETH trial published in NEJM in 2025. Kahlmann V, Janssen Bonás M, Moor CC, Grutters JC, Mostard RLM, van Rijswijk HNAJ, van der Maten J, Marges ER, Moonen LAA, Overbeek MJ, Koopman B, Loth DW, Nossent EJ, Wagenaar M, Kramer H, Wielders PLML, Bonta PI, Walen S, Bogaarts BAHA, Kerstens R, Overgaauw M, Veltkamp M, Wijsenbeek MS; PREDMETH Collaborators. First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate. N Engl J Med. 2025 Jul 17;393(3):231-242. doi: 10.1056/NEJMoa2501443. Epub 2025 May 18. PMID: 40387020. https://www.nejm.org/doi/full/10.1056/NEJMoa2501443 Meet Our Hosts Luke Hedrick is an Associate Editor at Pulm PEEPs and runs the Rapid Fire Journal Club Series. He is a senior PCCM fellow at Emory, and will be starting as a pulmonary attending at Duke University next year. Robert Wharton is a recurring guest on Pulm PEEPs as a part of our Rapid Fire Journal Club Series. He completed his internal medicine residency at Mt. Sinai in New York City, and is currently a first year pulmonary and critical care fellow at Johns Hopkins. Key Learning Points Clinical context Prednisone remains the traditional first-line treatment for pulmonary sarcoidosis when treatment is indicated, with evidence for short-term improvements in symptoms, radiographic findings, and pulmonary function—but with substantial, familiar steroid toxicities (weight gain, insomnia, HTN/DM, infection risk, etc.). Despite widespread use, glucocorticoids haven't been robustly tested head-to-head against many alternatives as initial therapy, and evidence for preventing long-term decline (especially in severe disease) is limited. Immunosuppressants (like methotrexate) are often used as steroid-sparing agents, but guideline recommendations are generally conditional/low-quality evidence, and practice varies. Why PREDMETH matters It addresses a real-world question: Can methotrexate be an initial alternative to prednisone in pulmonary sarcoidosis, rather than being reserved only for steroid-sparing later? It also probes a common clinical belief: MTX has slower onset than prednisone (often assumed, not well-proven). Trial design (what to know) Open-label, randomized, noninferiority trial across 17 hospitals in the Netherlands. Included patients with pulmonary sarcoidosis who had a clear pulmonary indication to start systemic therapy (moderate/severe symptoms plus objective risk features like reduced FVC/DLCO or documented decline, plus parenchymal abnormalities). Excluded: non–treatment-naïve patients and those whose primary indication was extrapulmonary disease. Treat-to-tolerability with escalation: both drugs started low and were slowly increased; switch/add-on allowed for inadequate efficacy or unacceptable side effects. Primary endpoint: change in FVC (with the usual caveat that FVC is “objective-ish,” but effort-dependent and not always patient-centered). Noninferiority margin: 5% FVC, justified as within biologic/measurement variation and “not clinically relevant.” Outcomes assessed at weeks 4, 16, 24; powered for ~110 patients to detect the NI margin. Patient population (who this applies to) Mostly middle-aged (~40s) with mild-to-moderate physiologic impairment on average (FVC ~77% predicted; DLCO ~70% predicted). Netherlands-based cohort with limited Black representation (~7%), which matters for generalizability. Would have been helpful to know more about comorbidities (e.g., diabetes), which can strongly influence prednisone risk. Main findings (what happened) Methotrexate was noninferior to prednisone at week 24 for FVC: Between-group difference in least-squares mean change at week 24: −1.17 percentage points (favoring prednisone) with CI −4.27 to +1.93, staying within the 5% NI margin. Timing mattered: Prednisone showed earlier benefit (notably by week 4) in FVC and across quality-of-life measures. By week 24, those early differences largely washed out—possibly because MTX “catches up,” and/or because crossover increased over time. In their reporting, MTX didn't meet noninferiority for FVC until week 24, supporting the practical message that prednisone works faster. Crossover and analysis nuance (important for interpretation) Crossover was fairly high, which complicates noninferiority interpretation: MTX arm: some switched to prednisone for adverse events and others had prednisone added for disease progression/persistent symptoms. Prednisone arm: some had MTX added. In noninferiority trials, heavy crossover can bias intention-to-treat analyses toward finding “no difference” (making noninferiority easier to claim). Per-protocol analyses avoid some of that but introduce other biases. They reported both. Safety signals (what to remember clinically) Adverse events were very common in both arms (almost everyone), mostly mild. Side-effect patterns fit expectations: Prednisone: more insomnia (and classic steroid issues). MTX: more headache/cough/rash, and notably liver enzyme elevations (about 1 in 4), with a small number discontinuing. Serious adverse events were rare; numbers were too small to confidently separate “signal vs noise,” but overall known risk profiles apply. Limitations (why you shouldn't over-read it) Open-label design, and FVC—while objective-ish—is still effort-dependent and can be influenced by expectation/behavior. Small trial, limiting subgroup conclusions (e.g., severity strata, different phenotypes). Generalizability issues (Netherlands demographics; US populations have higher rates of obesity/metabolic syndrome, which may tilt the steroid risk-benefit equation). Crossover reduces precision and interpretability of between-group differences over time. Practice implications (the “so what”) For many patients with pulmonary sarcoidosis needing systemic therapy, MTX is a reasonable initial alternative to prednisone when thinking long-term tolerability and steroid avoidance. Prednisone likely provides faster symptom/QoL relief in the first weeks—so it may be preferable when rapid improvement is important. The trial strengthens the case for a patient-centered discussion: short-term relief vs side-effect tradeoffs, and the possibility of early combination therapy in more severe cases (suggested, not proven).

Bill Saltmarsh joins me to discuss where a modern CDO gets the inspiration to “operate in the producty way” in his domain, which is healthcare. Now Vice President of Enterprise Data and Transformation and the Chief Data Officer at Children's Mercy Kansas City, his early days as an analyst revealed a gap between what stakeholders asked for vs. the outcomes they sought. This convinced him that data teams need to pause, ask better questions, and prioritize meaningful outcomes over quickly churning out dashboards and reports. Bill and I discuss how a producty mindset can be embedded across an organization. He also talks about why data leaders must set firm expectations. We explore the personal and cultural shifts needed for analysts and data scientists to embrace design, facilitation, and deeper discovery, even when it initially seems to slow things down. We also examine how to define value and ROI in healthcare, where a data team's impact is often indirect.  By tying data efforts to organizational OKRs and investing in governance, strong data foundations, and data literacy, he argues that analytics, data, and AI can drive better decisions, enhance patient care, and create durable organizational value. Highlights/ Skip to: What led Bill Saltmarsh to run his team at Children's Mercy “the producty way” (1:42)  The kinds of environments Bill worked in prior that influenced his current management philosophy (4:36) Why data teams shouldn't be report factories (6:37)  Setting the standard at the leadership level vs the everyday work (10:53) How Bill is skilling and hiring for non-technical skills (i.e. product, design, etc) (13:51)  Patterns that data professionals go through to know if they're guiding stakeholders correctly (20:54)  The point when Bill has to think about the financial side of the hospital (26:30) How Bill thinks about measuring the data team's  contributions to the hospital's success (30:28) Bill's philosophy on generative AI (36:00) Links Bill Saltmarsh on LinkedIn

In Episode 98 of The Lenders Playbook, host Matt Rosen dives into what happens when real estate deals don't go as planned—and how private lenders can protect themselves before problems arise.Our guest today is by Brock Berglund, a specialist in commercial foreclosures and loan workouts, we break down real-world scenarios, common lender misunderstandings, and practical strategies to avoid costly mistakes when deals go sideways.This episode is brought to you by Temple View Capital Funding, LP, a national private money lender offering flexible, common-sense financing for non-owner-occupied residential investment properties—helping investors close faster and scale smarter nationwide.American Lending ConferenceNational Private Lending EventMarch 10-11, 2026Las Vegas, Green Valley Ranchhttps://www.americanlendingconference.com/

In episode 64 of Going anti-Viral, we look back at the past year and beyond to share highlights from past episodes of the Going anti-Viral Podcast. In this selection of highlights, we share the remarkable outcomes of scientific research, hearing from researchers, clinicians, and survivors. These outcomes are the result of the tremendous work and innovation of our guests and the entire scientific research community and the investment of the American people in scientific research. 0:00 – Introduction 1:29 – Dr Judith Currier – Next-Gen HIV Prevention and Treatment 1:59 – Dr Anthony Fauci – A Conversation with Dr Anthony Fauci 2:33 – Dawn Averitt – A Personal Journey with HIV and Advocacy for HIV Research 3:18 – Rebecca Denison – 40+ Years of HIV: What's Changed, What Hasn't, What Shouldn't, What Must 3:44 – Dr Izukanji Sikazwe – Innovations in HIV Service Delivery: Building a Path Forward with Those Left Behind 4:19 – Dr Joseph Eron – HIV Cure Research: State of the Art and Navigating Presentations at CROI 2025 4:48 – Dr Diane Havlir – Preview of the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) 5:22 – Dr Peter Hotez – The Measles Outbreak and the Role Anti-Science Plays in Threatening Public Health 5:58 – Dr Steven Grinspoon – The Management of Cardiovascular Health in Patients with HIV 6:18 – Dr Ellen Eaton – Treating Substance Use Disorder in an Inpatient Setting 6:41 – Dr Khalil Ghanem – Demystifying Syphilis: Diagnosis and Treatment 7:01 – Dr Carlos del Rio – Providing Healthcare to Foreign-Born and Hard-to-Reach Individuals 7:37 – Dr Yvonne Maldonado – How Vaccines Get Approved in the US: The RSV Story and the Role of the ACIP 8:00 – Dr Demetre Daskalakis – The CDC without Scientific Leadership 8:29 – Dr Rochelle Walensky – The COVID-19 Pandemic and the Current State of Public Health in the US 9:01 – Mary Fisher – Breaking the Silence: An Activist's ApproachFor full episodes, visit the Going anti-Viral Podcast on Spotify and Apple Podcasts__________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Although prior ankle or subtalar arthrodesis is thought to affect outcomes at adjacent joints, previous studies have not distinguished between successful and failed prior fusions. This study examines whether prior successful vs failed ipsilateral arthrodesis influences nonunion risk in subsequent ankle or subtalar fusion. The primary objective of this study is to examine nonunion rates after subtalar and ankle arthrodesis in patients with and without prior ipsilateral arthrodesis, and vice versa. In conclusion, our analysis of the TriNetX Research Network database suggests that when the primary ankle or subtalar arthrodesis is successful, performing a subsequent adjacent fusion does not significantly increase the risk of nonunion compared with an isolated fusion. However, failed prior arthrodesis substantially increases nonunion risk, highlighting the importance of distinguishing between successful and failed prior procedures in clinical decision-making. Click here to read the article.

Incremental growth in the future across ecommerce and agentic commerce will be unlocked by two major AI-driven trends - increased scale with increased specificity. Higher discovery driven by specific use cases, higher conversion rates through personalized experiences, and delivered on vastly more endpoints and agentic conversations. To be part of these trends early means taking some big bets on AI transformation. The question is how? John Rossman, Author of Big Bet Leadership: Your Transformation Playbook for Winning in the Hyper-Digital Era, joins the podcast for a delicious conversation on the stack of pancakes you need to cook up to transform for seizing competitive advantage in the AI era.

This time Ned, Adam and Laura talk targets - and why the third Cycling and Walking Investment Strategy (CWIS3) needs outputs, not simply outcomes. They are joined by the CEO of the Walk, Wheel, Cycle Trust (formerly Sustrans), Xavier Brice, who knows all about strategies, and delivering active transport networks.The government recently ended a consultation on CWIS3 but, frustratingly, the proposals lacked any investment or much strategy. There were no SMART targets, or any outputs, i.e. routes; simply the unachievable outcome that by 2035 walking, wheeling and cycling will be "a safe, easy and accessible option for everyone". Road Investment Strategies, by contrast, focus heavily on routes and infrastructure, so why do we treat walking, wheeling and cycling differently?Xavier Brice has been CEO of the Walk Wheel Cycle Trust since 2016. In 2007 Brice led the development of a new walking and cycling strategy for London, with Transport for London.This month Adam, Laura and Xavier Brice coordinated an open letter to the Secretary of State supporting a better CWIS3. That letter was signed by more than 50 organisations across health, active travel and beyond. It asked that central government maps a true national network of routes by 2030, and sets targets to deliver that network to a proper, accessible standard by 2050.You can read the letter here: https://bsky.app/profile/adamtranter.bsky.social/post/3m7fv3vhyks2rThe letter was covered in the Guardian by Peter Walker: https://www.theguardian.com/politics/2025/dec/12/drivers-cyclists-transport-policy-conservatives-culture-wars-road-safety Shortly after that, Walker interviewed transport minister, Lilian Greenwood, about the importance of 'creating a system that works for everyone': https://www.theguardian.com/politics/2025/dec/12/drivers-cyclists-transport-policy-conservatives-culture-wars-road-safetyLaura's Freedom of Information requests to English local authorities found just 2 per cent had used legal powers to purchase land - something that's done routinely for roads https://substack.com/home/post/p-178788505And her article on CWIS3: https://lauralaker.substack.com/p/a-cycling-and-walking-strategy-walksThe Walk, Wheel Cycle Trust has been improving the National Cycle Network (NCN). In 2023/24 1.7km of an off-road muddy track connecting the residential area of Newton, in West Doncaster, to Danum retail park, was widened (on NCN62), with seven barriers removed or redesigned, along with improved wayfinding and signage. Estimated annual usage rose by 196% according to the Walk, Wheel Cycle Trust, from 150,000 trips in 2022 to 450,000 in 2024. Pedestrian and cycling trips increased by 191% and 192% respectively, while other users increased by 270%. Another path improvement project in Redcar and Cleveland saw ten barriers removed on NCN1 and NCN68. Wheelchair user trips increased four-fold, from 200 to 800, with 100% of disabled users saying they now use the route as the most convenient option.For ad-free listening, behind-the-scenes and bonus content and to help support the podcast - head to (https://www.patreon.com/StreetsAheadPodcast). We'll even send you some stickers! We're also on Bluesky and welcome your feedback on our episode: https://bsky.app/profile/podstreetsahead.bsky.social Hosted on Acast. See acast.com/privacy for more information.

Expecting a baby is stressful under the best of circumstances, but financial uncertainty can make it even harder. Ali Groves, Associate Professor at Drexel Dornsife School of Public Health and Research Chair of the mothers and Infants Cash Coalition, has spent years studying how cash transfers can improve reproductive and maternal health outcomes. Thomas McCullough, assistant archivist of the Moravian Church Northern Province, traced the deep historical roots behind one of Pennsylvania’s most recognizable holiday symbols: the Moravian star. McCullough explained that the Moravian Church dates back to 1457 and originated in what is now the Czech Republic, later spreading across Europe and eventually to Pennsylvania in 1740.Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

You skip breakfast, push through lunch, and tell yourself you'll eat later, but instead, your head starts pounding. What if fasting isn't helping your focus, but quietly stressing your brain into a migraine attack?In this episode of Migraine Heroes Podcast, host Diane Ducarme explores the paradox of fasting — why it can be both a healing tool and a hidden stressor for migraine-prone brains. With insights from neuroscience and Eastern medicine, you'll learn how to find your balance between cleansing and collapse.You'll discover:

This week we go back in time 2 years to review a recent paper from 2023 about outcomes of cardiac transplantation in the adult congenital heart patient (ACHD). Little has been written on this topic until this very robust and large scale report. How do single ventricle ACHD patients fair at transplant and how do they compare to non-ACHD heart transplant recipients? Why might 1 and 3 year outcomes not be a 'fair' method of assessing outcomes in this very high risk patient group? How do HLHS patient outcomes compare with other single ventricles? Are there better ways to measure risk in this patient group and how might the data in this work inform risk stratification and management of failing Fontan patients in whom transplantation is being considered? These are amongst the questions posed this week to the week's expert, Dr Daphne Hsu who is Professor of Pediatrics at the Albert Einstein College of Medicine at The Children's Hospital at Montefiore.https://doi.org/10.1016/j.jacc.2023.06.037For those interested in learning more about Dr. Hsu, take a listen to episode #166 from June, 2021:https://www.spreaker.com/episode/pediheart-podcast-166-a-conversation-with-professor-daphne-hsu--45144274

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from December 13-19, 2025.

As hospitals across the U.S. shorten length of stay and push more recovery into the home, families are increasingly left to manage complex care needs without formal training or support. Roughly one in five patients with chronic conditions like COPD or congestive heart failure is readmitted within 30 days—a cycle that costs the healthcare system billions annually and places enormous strain on caregivers. Against the backdrop of hospital-at-home models, aging demographics, and caregiver burnout, in-home senior care has become a critical piece of the post-acute care puzzle.So how can families ensure their loved ones are truly supported at home—not just medically, but functionally and emotionally—after discharge?In this episode of I Don't Care, host Dr. Kevin Stevenson sits down with Lance Summey, Franchise Owner at Home Instead. Together, they unpack the realities of nonmedical in-home senior care, how it integrates with hospitals, home health, and hospice, and why seemingly “small” daily tasks can dramatically impact health outcomes.Key Topics Covered in This Episode…Why nonmedical care matters: How help with activities of daily living—bathing, dressing, meals, transportation, and companionship—directly influences clinical outcomes and reduces hospital readmissions.Hospital-to-home transitions: The growing importance of in-home care as hospitals discharge patients earlier and rely on the home environment to support recovery.Caregiver burden and sustainability: Why family caregivers often reach a breaking point, and how professional in-home care allows loved ones to remain family—not full-time caregivers.Lance Summey is a franchise owner with Home Instead, the world's largest provider of nonmedical in-home senior care. He holds a Master's in Social Work from Baylor University and brings firsthand experience from both hospital systems and personal family caregiving. Motivated by his mother's battle with breast cancer and his grandmother's experience with multiple sclerosis, Summey has dedicated his career to bridging gaps in post-acute and long-term care—particularly where traditional medical models fall short. His work focuses on reducing hospital readmissions, integrating care teams, and supporting families through some of life's most challenging transitions.

In today's episode, we had the pleasure of speaking with Pooja M. Phull, MD, a hematologist/oncologist at the John Theurer Cancer Center at Hackensack University Medical Center in New Jersey, about emerging insights into the gut microbiome and its clinical relevance in multiple myeloma. Dr Phull discussed how microbial composition—particularly the presence of butyrate-producing bacteria—may influence therapeutic responsiveness, sustained minimal residual disease negativity, and long-term outcomes for patients undergoing autologous stem cell transplantation. In our exclusive interview, Dr Phull reviewed findings from a translational study that longitudinally profiled the fecal microbiome of patients with newly diagnosed myeloma, highlighting the significant post-transplant depletion of beneficial short-chain, fatty acid–producing organisms and its association with inferior progression-free survival. She also outlined supportive laboratory and in vivo data demonstrating the antitumor effects of butyrate and discussed how microbiome profiling may serve as both a predictive biomarker and a potential therapeutic target. Additionally, Dr Phull explored how dietary patterns, lifestyle factors, and antibiotic stewardship may contribute to preserving gut microbial health, and she emphasized the growing need for prospective studies to clarify how these interventions could enhance treatment outcomes for patients with active myeloma and precursor conditions such as monoclonal gammopathy of undetermined significance and smoldering myeloma.

You're listening to American Ground Radio with Stephen Parr and Louis R. Avallone. This is the full show for December 17, 2025. 0:30 Breaking news out of Washington: FBI Deputy Director Dan Bongino is set to leave the Bureau early next year — and while this isn’t a scandal, it is a moment worth watching. Bongino’s short tenure at the FBI raises real questions about leadership, culture, and whether outspoken media figures can thrive inside a process-heavy federal agency. We dive into why Bongino may be better suited for influence behind a microphone than inside the bureaucracy, what his exit signals for FBI Director Kash Patel and Attorney General Pam Bondi, and how recent FBI wins and missteps factor into the bigger picture. 9:00 Plus, we cover the Top 3 Things You Need to Know. President Trump has ordered a Naval blockade of Venezuela. Four Republican broke from their party to force a house vote on extending Democrat designed subsidies for the Democrat designed Affordable Care Act. Republican Congressman Dan Newhouse is not seeking reelection to Congress next year. 11:30 Get Prodovite Plus from Victory Nutrition International for 20% off. Go to vni.life/agr and use the promo code AGR20. 12:00 A new YouGov poll exposes a sharp political divide on immigration — and the numbers are hard to ignore. Only 17 percent of Democrats say legal immigration should be reduced, compared to 66 percent of Republicans who want it cut back or ended altogether. We dig into what those numbers really mean, the difference between legal and illegal immigration, and why border enforcement has become a breaking point even for many Democrats after the Biden administration’s failures. 15:00 American Mamas Teri Netterville and Kimberly Burleson take on the controversy surrounding Trump Chief of Staff Susie Wiles and her decision to sit down with Vanity Fair — and why many conservatives see it as a major miscalculation. We break down how a year-long interview turned into headline-grabbing quotes about Trump, JD Vance, and the White House inner circle, how off-the-record trust was allegedly weaponized, and why legacy media outlets are viewed as hostile territory for Republicans. The Mamas also unpack media bias, selective framing, and the broader lesson about walking into the “lion’s den” of left-leaning press — even when you think you’re being careful. If you'd like to ask our American Mamas a question, go to our website, AmericanGroundRadio.com/mamas and click on the Ask the Mamas button. 22:00 We dive into reports of new plaques placed beneath presidential portraits in the White House — and the controversy they’ve sparked. Do these bronze plaques represent historical record or political trolling? And where the line is between blunt truth-telling and misuse of taxpayer dollars? We discuss President Trump’s unapologetic style, the difference between opinion and history, and whether America’s obsession with politeness has replaced honest evaluation of past presidents. 25:30 We Dig Deep into the nation’s largest teachers union after reports that the NEA is promoting so-called “neo-pronouns” and “zeo-pronouns” in teacher training sessions. This isn’t education reform — it’s ideological activism replacing basic grammar, clarity, and classroom priorities. We question why unions are focusing on made-up language and identity politics instead of improving student outcomes, and warning that redefining words isn’t about communication but control. 31:00 Get TrimROX from Victory Nutrition International for 20% off. Go to vni.life/agr and use the promo code AGR20. 31:30 We break down President Trump's prime-time address, and it's a deliberate moment of leadership where he plans to highlight his administration’s accomplishments and preview what he calls America’s “golden age.” Speaking directly to the nation on major networks still matters, even in an era dominated by social media. 34:00 And we have a Bright Spot from Florida, where the state can now enforce a ban on sexually explicit drag performances in front of minors. It's a long-overdue correction, and should never have been treated as protected speech when children were involved. We break down court battle that led to the decision, the narrow exception that still exists, and the broader cultural fight over bringing adult performance art into kids’ spaces like libraries and classrooms. This isn’t about censoring adults, it's about drawing a clear line between free speech and exposing children to sexualized content — a line that should have never been blurred in the first place. 38:30 In Texas, Republican Senate candidate Wesley Hunt is pushing a proposal to block education benefits for illegal immigrants — a move that's long overdue. With millions of illegal immigrants already in the country, full deportation isn’t realistic. Self-deportation was always part of the strategy. By cutting off benefits like public education, families will choose to leave on their own. It's a tough, controversial approach — but one that finally confronts why illegal immigration persists in the first place. 40:30 And we finish off today’s show with a little tech history that quietly reshaped the modern world. On this day in 1994, Netscape Navigator 1.0 hit the market and opened the door for everyday people to actually use the internet. Long before Chrome, Safari, or Firefox, Netscape was how the web worked — the browser that made surfing possible and set the standard for everything that followed. Follow us: americangroundradio.com Facebook: facebook.com / AmericanGroundRadio Instagram: instagram.com/americangroundradioSee omnystudio.com/listener for privacy information.

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he and Doctor Reike Alten will be reviewing two papers. The first paper by Kameda et al. assessed long-term safety and efficacy of UPA over 5 years in Japanese patients with moderate-to- severe active RA and an inadequate response to stable doses of csDMARDs-IR. The second paper by Salvato et al. assessed the impact of chronic oral low-dose GCs on the efficacy and retention rates of JAK inhibitors compared to other mechanisms of action therapies in a cohort of RA patients with inadequate response to TNFi.

The Industry Relations Podcast is now available on your favorite podcast player! Overview Rob Hahn and Greg Robertson dig into the escalating conflict between Zillow and MRED over private listing networks (PLNs), IDX rules, and Zillow's Listing Access Standards (ZLAS). What starts as a dispute over listing visibility quickly becomes a deeper conversation about power: who ultimately controls listing data—the MLS or the portal? The episode explores MRED's emails to brokers, Zillow's outreach for direct feeds, potential January disruptions, and why this fight could set a precedent for MLS–portal relationships nationwide.  Key Takeaways Zillow and MRED are on a collision course over whether Zillow can selectively exclude PLN listings while still receiving IDX feeds.  MRED argues selective exclusion violates its IDX rules; Zillow argues it owes transparency to sellers and consistency to its standards.  Emails suggest Zillow may pursue direct broker feeds, potentially bypassing the MLS if access is cut off.  The dispute is less about private listings themselves and more about control—"who runs Barter Town."  Outcomes range from MLS dominance, to Zillow dominance, to a hard-to-define compromise—with major implications for brokers, sellers, and other MLSs. Links Zillow stalemate with Chicago's MLS looks like it's coming to a head Mad Max Clip   Connect with Rob and Greg Rob's Website  Greg's Website    Watch us on YouTube   Our Sponsors: Cotality  Notorious VIP The Giant Steps Job Board    Production and Editing Services by Sunbound Studios

JHLT: The Podcast returns with an episode discussing the paper, "High Antiphospholipid Antibody Titers and Outcomes of Pulmonary Endarterectomy: A Single-Center Retrospective Observational Cohort Study," from the December issue of JHLT.   They are joined by the first author, Camille Miard, MD, and senior author, François Stéphan, MD, PhD, both from the cardiothoracic intensive care unit at Hôpital Marie Lannelongue in Paris.   The discussion explores: Whether antiphospholipid antibody titers could predict postoperative outcomes for CTEPH patients undergoing pulmonary endarterectomy (PEA) How APS patients differed from non-APS patients in the PEA cohort The changes in clinical practice at Marie Lannelongue after the study's findings   For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.   Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Bob Farrell, CEO of mPulse, is using digital technology, data analytics and AI to improve the relationship between health plans and their members in order to improve health outcomes and operational efficiency. Bob introduces the concept of HXI, Health Experience and Insights, as a framework that unites data, intelligence, and personalized communication to provide tools to enage members at the best time and by the preferred methods with appropriate information at the right time. Analyzing claims data enables plans to identify high-risk patients, promote preventive care, and build health literacy. Bob explains, "The mission of mPulse, and this has really been the mission of the company since its founding in 2015, is to improve the health outcomes of our customers' members and patients. So we're looking to close gaps in care. We're looking to increase literacy so that members and patients can understand their health plans. So providers can take charge of healthcare and improve those outcomes. And while we're doing that, we try to help our customers improve their operational efficiencies. Most of our customers are health plans and they range from small community plans to large nationals. The 60 largest plans are our customers. We have a wide array of customers and continue to expand on that base, both with new customers and by doing more with the customers that we have."   "Health plans are not known to be the early adopters of technology. So you're right. A lot of them are still transitioning from older ways of doing things. But in general, health plans have a huge trust issue with their members, and it has really resulted from a lack of engagement, a lack of positive experience. So we see a lot of health plans looking to embrace technology to improve the member experience, make sure that those members are getting outreach. Not just now and then, but during the whole course of their consumer health journey, so that they can be aware of what things they have available to them, so that they can easily adjudicate claims and easily find providers."    #mPulse #HXI #PersonalizedCare #HealthExperienceInsights #DigitalHealth mPulse.com Listen to the podcast here  

Many founders wait for the “perfect moment” to sell or fixate on hitting a specific valuation target, but both can lead to missed opportunities. In this episode, Sarah Letourneau from Goldman Sachs joins Mike Lyon to discuss the most common mistakes they see founders make on the path to an exit; from waiting too long to run a process, to anchoring on a headline number, to assembling the wrong deal team. They share how to plan ahead, build the right advisors around you, and make informed decisions that support both your transaction and your life after the deal.Securities offered through Vista Point Advisors, member FINRA/SIPC. This has been provided for informational purposes only and should not be considered as investment advice or a recommendation. It is not intended to address all circumstances that might arise. The views expressed herein may change at any time subsequent to the date of issue. Opinions contained herein should not be interpreted as a guarantee of future results. Outcomes will vary depending on individual circumstances. Any examples used in this material are generic, hypothetical and for illustration purposes only. Testimonials from past clients may not be representative of the experience of other clients and there is no guarantee of future performance or success. Clients are not compensated for their comments.

The FiltrateJoel Topf‍ ‍@kidneyboy.bsky.social‬ (COI)Swapnil Hiremath @hswapnil.medsky.social and on LinkedInPedro Teixeira @nephcrit.bsky.socialSpecial Guests Charmaine E Lok, MD Professor of Medicine at the Faculty of Medicine, University of TorontoEditing and Show Notes byJoel TopfThe Kidney Connection written and performed by Tim YauShow NotesFish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis NEJM | NephJCWhat works in hemodialysis?Iron: PIVOTAL Trial (NEJM)Hemodiafiltration: CONVINCE (NEJM)That's the whole listEarlier work on vascular access, The FISH Trial: Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial JAMAEskimo myth: "Fishing" for the origins of the "Eskimos and heart disease" story: facts or wishful thinking? (PubMed)Dialysis patients have low levels of fish oil in their body (PubMedCentral)Positive trial in non-dialysis patients: REDUCE-ITNegative trial of fish oil in non-dialysis patients: STRENGTHACC does not recommend FISH Oil for primary or secondary prevention of CV events (ACC)Poisson distribution (Wikipedia)Ocean Nutrition Canada (Wikipedia)Ocean Nutrition was bought by DSM (Press Release)DSM merged with Firmenich (Press Release)Vanguard feasibility trials (PubMed)Freezing fish oil caps will eliminate the fishy aftertaste (Pharmacists Letter)The study also received a philanthropic donation from Mr. Alexander Epstein (UHN Research)Selection Bias, Interventions and Outcomes for Survivors of Cardiac Arrest (PubMedCentral)Effectiveness of fish oil in controlling inflammation in adult patients undergoing hemodialysis: A systematic review and meta-analysis (PubMed)Tubular SecretionsSwapnil Hiremath: Michael Clayton (IMDB)Pedro: Fifa World Cup Soccer coming to North America with Portugal! (FIFA)Charmaine: New Puppy, Rose. It's a Barbet (Wikipedia)Joel Topf: The Dark Forrest by Liu Cixin (Wikipedia)

AI investments? Everywhere. AI training? .......

Dr. Fei-Fei Li (@drfeifei) is the inaugural Sequoia Professor in the Computer Science Department at Stanford University, a founding co-director of Stanford's Human-Centered AI Institute, and the co-founder and CEO of World Labs, a generative AI company focusing on Spatial Intelligence. She is the author of The Worlds I See: Curiosity, Exploration, and Discovery at the Dawn of AI, her memoir and one of Barack Obama's recommended books on AI and a Financial Times best book of 2023.This episode is brought to you by:Seed's DS-01® Daily Synbiotic broad spectrum 24-strain probiotic + prebiotic: https://seed.com/timHelix Sleep premium mattresses: https://helixsleep.com/timCoyote the card game​, which I co-created with Exploding Kittens: https://coyotegame.com/Wealthfront high-yield cash account: https://wealthfront.com/timNew clients get 3.50% base APY from program banks + additional 0.65% boost for 3 months on your uninvested cash (max $150k balance). Terms apply. The Cash Account offered by Wealthfront Brokerage LLC (“WFB”) member FINRA/SIPC, not a bank. The base APY as of 11/07/2025 is representative, can change, and requires no minimum. Tim Ferriss, a non-client, receives compensation from WFB for advertising and holds a non-controlling equity interest in the corporate parent of WFB. Experiences will vary. Outcomes not guaranteed. Instant withdrawals may be limited by your receiving firm and other factors. Investment advisory services provided by Wealthfront Advisers LLC, an SEC-registered investment adviser. Securities investments: not bank deposits, bank-guaranteed or FDIC-insured, and may lose value.*For show notes and past guests on The Tim Ferriss Show, please visit tim.blog/podcast.For deals from sponsors of The Tim Ferriss Show, please visit tim.blog/podcast-sponsorsSign up for Tim's email newsletter (5-Bullet Friday) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim's books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissYouTube: youtube.com/timferrissFacebook: facebook.com/timferriss LinkedIn: linkedin.com/in/timferrissSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.